Medical Laboratory Scientist – Molecular Pathology Full-time Permanent Dunedin About the company | Mo Matou Awanui Labs - Dunedin has provided doctors and patients in New Zealand with pathology services since 1960. Awanui has laboratories throughout the country and is committed to providing facilities and services that deliver exceptional care to its clients. Our team consists of talented and skilled individuals, all of whom play an important role in helping us to be New Zealand's leading provider of quality private healthcare services.
About the role | Nga korero mo te turanga Our busy Dunedin Laboratory provides service to both the Hospital and Community and is looking for a qualified Medical Laboratory Scientist to work in the Molecular Pathology department. Your role will see you performing both routine and specialised tests with a high degree of skill and confidence.
This is a permanent full-time role (80 hours per fortnight) and whilst core hours are Monday to Friday 8.30am to 5.30pm, flexibility with the roster including weekends and evening/night shifts is required.
About you | He korero mou To be considered for this role you will need, or be able to obtain:
Full registration with the Medical Sciences Council of New Zealand. A current Annual or Interim Practicing Certificate. A good understanding of molecular testing. The ability to work in a methodical manner, and demonstrate attention to detail. The ability to work both independently and as part of a dynamic team. Interested candidates must be team players with initiative, good interpersonal and communication skills and possess the ability to work in a fast-paced, deadline-oriented environment.
The successful applicant will be customer-focused and committed to providing an excellent service to the greater community. If you are passionate about your work, dedicated to quality and want to be part of a friendly, supportive team then we want to hear from you.
We will review applications as received and the position may close before end date.
Applications close 1st November 2024
#J-18808-Ljbffr